Cargando…
Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study
BACKGROUND: Given that treatments for chronic lymphocytic leukaemia (CLL) are palliative rather than curative, evaluating the patient-perceived impacts of therapy is critical. To date, no utility (preference) studies from the general public or patient perspective have been conducted in CLL. The obje...
Autores principales: | Beusterien, Kathleen M, Davies, John, Leach, Michael, Meiklejohn, David, Grinspan, Jessica L, O'Toole, Alison, Bramham-Jones, Steve |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890699/ https://www.ncbi.nlm.nih.gov/pubmed/20482804 http://dx.doi.org/10.1186/1477-7525-8-50 |
Ejemplares similares
-
Patient preferences for chemotherapies used in breast cancer
por: Beusterien, Kathleen, et al.
Publicado: (2012) -
Patient preferences in the treatment of diabetic retinopathy
por: Wirostko, Barbara, et al.
Publicado: (2011) -
The Uptake and Utilization of Chlorambucil by Lymphocytes from Patients with Chronic Lymphocytic Leukaemia
por: Hill, Bridget T., et al.
Publicado: (1972) -
Dasatinib Inhibits CXCR4 Signaling in Chronic Lymphocytic Leukaemia Cells and Impairs Migration Towards CXCL12
por: McCaig, Alison M., et al.
Publicado: (2012) -
Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema
por: Aygören-Pürsün, Emel, et al.
Publicado: (2016)